Becoming Without: Making Transgenic Mosquitoes and Disease Control in Brazil
By Luísa Reis-Castro,
Duke University Press
| 11. 01. 2021
The First Bite
At the end of a day of fieldwork in Juazeiro, a city in Northeast Brazil, I sat in bed trying to write up my notes. A noisy fan in my small room was not alleviating the suffocating heat, so I moved to the porch to breath in some fresh air. Not long after I sat down, an itch on my left arm prompted a quick swat from my right hand. I turned my hand over to see a dead mosquito, with blood smeared on my skin. During my stay in Juazeiro, in the semiarid region of the Bahia state, mosquitoes, which in this region are broadly called muriçocas, were a constant presence. The itchiness caused by their bites is a nuisance, but they can also be dangerous: some mosquitoes convey disease pathogens. As I inspected the dead mosquito that afternoon my trained eye recognized its black-and-white stripes as a telltale signature of the Aedes aegypti, a species notorious for transmitting viruses such as dengue, chikungunya, Zika, and (urban) yellow fever.
It was the A. aegypti...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...